VUMC

Vanderbilt University announced seven recipients of the Innovation Catalyst Fund awards for the June 2026 cycle. These awards offer strategic pre-seed funding to help Vanderbilt faculty turn promising research concepts into solutions that address fundamental societal needs. The selected research projects span a range of disciplines, from Biosciences and… Read More

The U.S. Food and Drug Administration cleared Heartvue.Proton (K260811), an AI-powered software platform for cardiac MRI built on technology developed by Vanderbilt University Medical Center researchers. Jeffrey Dendy, a Vanderbilt cardiologist and imaging specialist, co-developed the underlying method with Heartvue.AI, and protected the innovation through the Vanderbilt Center for… Read More

Vanderbilt University announced 10 recipients of the Innovation Catalyst Fund awards for the February 2026 cycle, advancing faculty-led research projects with the potential to address critical societal and health care challenges through translational research. The awards provide strategic funding to support faculty’s technologies from a broad range of disciplines… Read More

Jun 03, 2026 Image Presenting: Miranda Collier, PhD, Principal Scientist, External Innovation, GondolaBio The Vanderbilt Industry Collaborations team recently welcomed Gondola Bio, a privately held biopharmaceutical company spun out of BridgeBio Pharma and focused on developing therapeutics for genetically defined diseases, for a two-day campus visit coordinated by Swapneeta… Read More

Jennifer Pietenpol, Jeffrey Dendy, and Ken Holroyd at the 2024 Brock Center Innovator of the Year Lecture. Photo Credit: VUMC For cardiologists interpreting cardiac MRI scans, the process is often time-intensive, repetitive, and vulnerable to workflow bottlenecks that contribute to physician burnout. Heartvue.AI is working to change that. Founded by… Read More

Paul Harris, Ph.D., receiving an award from Linda Cottler, Ph.D., M.P.H., president of ACTS. Photo credit: VUMC. In the early 2000s, Paul Harris, Ph.D. was finishing his biomedical engineering degree at Vanderbilt University, when a part-time job fixing computers at the VUMC’s Clinical Research Center unexpectedly launched… Read More

Ken is the CTTC Medical Director. Russelle Bradbury, Daniel Fabbri, PhD, and Ken Holroyd, MD, MBA (Photo Credit: Erin O. Smith) Ken Holroyd, MD, MBA, joined Vanderbilt University in 2005. He currently serves as the Center for Technology Transfer and Commercialization‘s Medical Director, the lead of… Read More

Vanderbilt has announced eleven awardees in the latest round of its Innovation Catalyst Fund, an initiative that supports translational research that has promising commercial potential. This initiative, open to all University and Vanderbilt University Medical Center (VUMC) faculty, addresses pressing real-world challenges. The fund provides essential support in three key areas:… Read More